Zu QQ - Search Results

1

Transarterial chemoembolization combined with molecular targeted agents plus immune checkpoint inhibitors for unresectable hepatocellular carcinoma beyond the up-to-seven criteria: a propensity score-matching analysis.

Chen W, Yan HT, Zhang JX, Zhou CG, Liu J, Liu S, Shi HB, Cheng Y, Zu QQ. Chen W, et al. Among authors: zu qq. Ann Med. 2024 Dec;56(1):2419993. doi: 10.1080/07853890.2024.2419993. Epub 2024 Nov 1. Ann Med. 2024. PMID: 39484705

2

Efficacy of Atezolizumab Plus Bevacizumab Combined with Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Real-World Study.

Shen X, Zhang JX, Liu J, Liu S, Shi HB, Cheng Y, Zhang QQ, Yin GW, Zu QQ. Shen X, et al. Among authors: zu qq. J Hepatocell Carcinoma. 2024 Oct 21;11:1993-2003. doi: 10.2147/JHC.S478604. eCollection 2024. J Hepatocell Carcinoma. 2024. PMID: 39465042 Free PMC article.

3

Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors Versus Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma with First- or Lower-Order Portal Vein Tumor Thrombosis.

Zhang JX, Cheng Y, Wei J, Fan WL, Liu J, Zhou CG, Liu S, Shi HB, Chu XY, Zheng WL, Zu QQ. Zhang JX, et al. Among authors: zu qq. Cardiovasc Intervent Radiol. 2024 Jun;47(6):751-761. doi: 10.1007/s00270-024-03724-x. Epub 2024 Apr 26. Cardiovasc Intervent Radiol. 2024. PMID: 38671322

4

Efficacy and Safety of TACE Combined with a Tyrosine Kinase Inhibitor for the Treatment of TACE-Refractory Hepatocellular Carcinoma: A Retrospective Comparative Study.

Chen YX, Zhang JX, Zhou CG, Liu J, Liu S, Shi HB, Zu QQ, Cheng Y. Chen YX, et al. Among authors: zu qq. J Gastrointest Cancer. 2024 Jun;55(2):924-931. doi: 10.1007/s12029-024-01036-4. Epub 2024 Mar 12. J Gastrointest Cancer. 2024. PMID: 38470522

5

Role of Transarterial Chemoembolization in the Era of Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor Combination Therapy for Unresectable Hepatocellular Carcinoma: A Retrospective Propensity Score Matched Analysis.

Zhang JX, Hua HJ, Cheng Y, Liu S, Shi HB, Zu QQ. Zhang JX, et al. Among authors: zu qq. Acad Radiol. 2024 Apr;31(4):1304-1311. doi: 10.1016/j.acra.2023.09.001. Epub 2023 Sep 27. Acad Radiol. 2024. PMID: 37775449

6

Does the presence of systemic artery-pulmonary circulation shunt during bronchial arterial embolization increase the recurrence of noncancer-related hemoptysis? A retrospective cohort study.

Yan HT, Lu GD, Liu J, Liu S, Shi HB, Zhou CG, Zu QQ. Yan HT, et al. Among authors: zu qq. Respir Res. 2023 May 2;24(1):119. doi: 10.1186/s12931-023-02427-0. Respir Res. 2023. PMID: 37131263 Free PMC article.

7

Comparison of Bronchial Artery Embolisation Versus Conservative Treatment for Bronchiectasis-Related Nonmassive Haemoptysis: A Single-Centre Retrospective Study.

Yan HT, Lu GD, Zhang JX, Zhou CG, Liu J, Liu S, Shi HB, Zu QQ. Yan HT, et al. Among authors: zu qq. Cardiovasc Intervent Radiol. 2023 Mar;46(3):369-376. doi: 10.1007/s00270-023-03361-w. Epub 2023 Jan 19. Cardiovasc Intervent Radiol. 2023. PMID: 36658375

8

Bronchial artery embolization for the management of frequent hemoptysis caused by bronchiectasis.

Lu GD, Yan HT, Zhang JX, Liu S, Shi HB, Zu QQ. Lu GD, et al. Among authors: zu qq. BMC Pulm Med. 2022 Nov 1;22(1):394. doi: 10.1186/s12890-022-02198-2. BMC Pulm Med. 2022. PMID: 36319977 Free PMC article.

9

Comparison of the Efficacy and Safety of Transarterial Chemoembolization with or without Lenvatinib for Unresectable Hepatocellular Carcinoma: A Retrospective Propensity Score-Matched Analysis.

Chen YX, Zhang JX, Zhou CG, Liu J, Liu S, Shi HB, Zu QQ. Chen YX, et al. Among authors: zu qq. J Hepatocell Carcinoma. 2022 Aug 1;9:685-694. doi: 10.2147/JHC.S373250. eCollection 2022. J Hepatocell Carcinoma. 2022. PMID: 35937909 Free PMC article.

10

Acute embolic stroke with large-vessel occlusion: does contact aspiration thrombectomy show superiority?

Qiu K, Zhao LB, Xu XQ, Wang Y, Liu J, Liu S, Shi HB, Zu QQ. Qiu K, et al. Among authors: zu qq. Clin Radiol. 2022 Aug;77(8):577-583. doi: 10.1016/j.crad.2022.05.020. Epub 2022 Jun 23. Clin Radiol. 2022. PMID: 35753814

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters